News and Trends 22 Jun 2022
Cystic fibrosis in the crosshairs as Carbon Biosciences launches with $38M funding
Carbon Biosciences, a Longwood Fund founded biotech company developing parvovirus-derived gene therapies, has launched with $38 million of financing led by Agent Capital. Agent is joined by Longwood Fund, Astellas…